SELLAS Life Sciences
SLS on XNAS, SELLAS Life Sciences Group, Inc.
Measures activity, not value. Not investment advice.
Shares sold short (30 Oct 2026)
57.1M
+6.3% vs the report before
Short interest, % of shares outstanding
28%
203.9M shares outstanding (11 Nov 2026)
Days to cover
6.7
short interest / daily volume
Short sale volume share (20 Nov 2026)
57%
1-year median 59%
Sharp changes
30
short interest spike
FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.
See the numbers
| 30 Oct 2026: 57.1M shares sold short, 6.7 days to cover |
| 15 Oct 2026: 53.8M shares sold short, 11.9 days to cover |
| 30 Sep 2026: 55.1M shares sold short, 9.4 days to cover |
| 15 Sep 2026: 59.1M shares sold short, 8.6 days to cover |
| 31 Aug 2026: 57.9M shares sold short, 6.9 days to cover |
| 14 Aug 2026: 56.4M shares sold short, 10.4 days to cover |
| 31 Jul 2026: 55.0M shares sold short, 7.9 days to cover |
| 15 Jul 2026: 55.3M shares sold short, 5.9 days to cover |
| 30 Jun 2026: 63.3M shares sold short, 4.8 days to cover |
| 15 Jun 2026: 63.4M shares sold short, 9.2 days to cover |
| 29 May 2026: 61.0M shares sold short, 4.4 days to cover |
| 15 May 2026: 57.1M shares sold short, 7.1 days to cover |
| 30 Apr 2026: 57.1M shares sold short, 11.7 days to cover |
| 15 Apr 2026: 56.6M shares sold short, 13.6 days to cover |
| 31 Mar 2026: 53.5M shares sold short, 6.0 days to cover |
| 13 Mar 2026: 45.8M shares sold short, 6.2 days to cover |
| 27 Feb 2026: 49.1M shares sold short, 7.8 days to cover |
| 13 Feb 2026: 46.1M shares sold short, 10.0 days to cover |
| 30 Jan 2026: 41.3M shares sold short, 6.3 days to cover |
| 15 Jan 2026: 42.0M shares sold short, 2.6 days to cover |
| 31 Dec 2025: 49.4M shares sold short, 4.3 days to cover |
| 15 Dec 2025: 40.5M shares sold short, 7.1 days to cover |
| 28 Nov 2025: 33.3M shares sold short, 10.2 days to cover |
| 14 Nov 2025: 31.8M shares sold short, 8.9 days to cover |
| 31 Oct 2025: 29.0M shares sold short, 4.7 days to cover |
| 15 Oct 2025: 25.1M shares sold short, 7.2 days to cover |
| 30 Sep 2025: 23.1M shares sold short, 9.6 days to cover |
| 15 Sep 2025: 20.9M shares sold short, 11.0 days to cover |
| 29 Aug 2025: 29.3M shares sold short, 13.6 days to cover |
| 15 Aug 2025: 29.2M shares sold short, 19.4 days to cover |
| 31 Jul 2025: 26.4M shares sold short, 12.3 days to cover |
| 15 Jul 2025: 27.7M shares sold short, 7.8 days to cover |
| 30 Jun 2025: 24.4M shares sold short, 5.6 days to cover |
| 13 Jun 2025: 18.9M shares sold short, 8.0 days to cover |
| 30 May 2025: 12.2M shares sold short, 3.6 days to cover |
| 15 May 2025: 8.8M shares sold short, 3.3 days to cover |
| 30 Apr 2025: 7.7M shares sold short, 4.1 days to cover |
| 15 Apr 2025: 7.8M shares sold short, 6.8 days to cover |
| 31 Mar 2025: 8.2M shares sold short, 9.2 days to cover |
| 14 Mar 2025: 7.8M shares sold short, 8.8 days to cover |
| 28 Feb 2025: 7.8M shares sold short, 6.3 days to cover |
| 14 Feb 2025: 8.7M shares sold short, 3.5 days to cover |
| 31 Jan 2025: 9.8M shares sold short, 1.2 days to cover |
| 15 Jan 2025: 9.0M shares sold short, 6.0 days to cover |
| 31 Dec 2024: 8.0M shares sold short, 7.2 days to cover |
| 13 Dec 2024: 7.5M shares sold short, 3.5 days to cover |
| 29 Nov 2024: 9.0M shares sold short, 8.8 days to cover |
| 15 Nov 2024: 8.8M shares sold short, 11.2 days to cover |
| 31 Oct 2024: 8.6M shares sold short, 13.1 days to cover |
| 15 Oct 2024: 6.1M shares sold short, 12.5 days to cover |
| 30 Sep 2024: 8.2M shares sold short, 17.5 days to cover |
| 13 Sep 2024: 8.2M shares sold short, 18.0 days to cover |
| 30 Aug 2024: 8.2M shares sold short, 16.8 days to cover |
| 15 Aug 2024: 7.7M shares sold short, 12.6 days to cover |
| 31 Jul 2024: 10.7M shares sold short, 9.6 days to cover |
| 15 Jul 2024: 9.7M shares sold short, 17.0 days to cover |
| 28 Jun 2024: 8.9M shares sold short, 5.1 days to cover |
| 14 Jun 2024: 7.6M shares sold short, 7.5 days to cover |
| 31 May 2024: 7.6M shares sold short, 10.9 days to cover |
| 15 May 2024: 7.3M shares sold short, 4.5 days to cover |
What the numbers say
- 57.1M shares sold short on 30 Oct 2026, 28% of shares outstanding, 6.7 days to cover; +6.3% on the report before (published by FINRA on 10 Nov 2026).
Every measure from this source
Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.
Sharp changes
30 in all loaded history, strongest first
SELLAS Life Sciences had 31.8M shares sold short in the 14 Nov 2025 report, 3.6× the same report last year.
Same report last year: 8.8M; its normal report is 9.4M.
See the evidence
- This period
- 31.8M (the 14 Nov 2025 report)
- Normal report (median of 24 earlier)
- 9.4M
- Typical spread (median absolute deviation)
- 1.8M
- How far from its usual level
- +8.2
- Same report last year
- 8.8M
- History used
- 2,863 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
SELLAS Life Sciences had 29.3M shares sold short in the 29 Aug 2025 report, 3.6× the same report last year.
Same report last year: 8.2M; its normal report is 8.6M.
See the evidence
- This period
- 29.3M (the 29 Aug 2025 report)
- Normal report (median of 24 earlier)
- 8.6M
- Typical spread (median absolute deviation)
- 806K
- How far from its usual level
- +17.3
- Same report last year
- 8.2M
- History used
- 2,786 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
SELLAS Life Sciences had 29.2M shares sold short in the 15 Aug 2025 report, 3.8× the same report last year.
Same report last year: 7.7M; its normal report is 8.4M.
See the evidence
- This period
- 29.2M (the 15 Aug 2025 report)
- Normal report (median of 24 earlier)
- 8.4M
- Typical spread (median absolute deviation)
- 621K
- How far from its usual level
- +22.5
- Same report last year
- 7.7M
- History used
- 2,772 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
SELLAS Life Sciences had 29.0M shares sold short in the 31 Oct 2025 report, 3.4× the same report last year.
Same report last year: 8.6M; its normal report is 9.0M.
See the evidence
- This period
- 29.0M (the 31 Oct 2025 report)
- Normal report (median of 24 earlier)
- 9.0M
- Typical spread (median absolute deviation)
- 1.3M
- How far from its usual level
- +10.5
- Same report last year
- 8.6M
- History used
- 2,849 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
SELLAS Life Sciences had 27.7M shares sold short in the 15 Jul 2025 report, 2.9× the same report last year.
Same report last year: 9.7M; its normal report is 8.4M.
See the evidence
- This period
- 27.7M (the 15 Jul 2025 report)
- Normal report (median of 24 earlier)
- 8.4M
- Typical spread (median absolute deviation)
- 621K
- How far from its usual level
- +21.0
- Same report last year
- 9.7M
- History used
- 2,741 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
SELLAS Life Sciences had 26.4M shares sold short in the 31 Jul 2025 report, 2.5× the same report last year.
Same report last year: 10.7M; its normal report is 8.4M.
See the evidence
- This period
- 26.4M (the 31 Jul 2025 report)
- Normal report (median of 24 earlier)
- 8.4M
- Typical spread (median absolute deviation)
- 621K
- How far from its usual level
- +19.6
- Same report last year
- 10.7M
- History used
- 2,757 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.